Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feifei Tang

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Science China. Life Sciences|August 18, 2019
Comparison of the clinical outcomes of hematologic malignancies after myeloablative haploidentical transplantation with G-CSF/ATG and posttransplant cyclophosphamide: results from the Chinese Bone Marrow Transplantation Registry Group (CBMTRG)Feifei Tang, Yajing Xu, Huiren Chen, et al.
Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan|April 7, 2021
Mechanism underlying effect of Chaihu Shugan San on major depressive disorder: a network pharmacology-based studyJie Mu, Shuang Zhang, Feifei Tang, et al.
Leukemia Research|February 13, 2026
Venetoclax and azacitidine versus CAG for unfit patients with newly diagnosed acute myeloid leukemia: A propensity score-matched analysisGuanghui Chang, Haitao Gao, Yan Wei, et al.
Hematological Oncology|June 5, 2023
The effect of haploidentical hematopoietic stem cell transplantation on comutations based on next-generation sequencing in adult acute myeloid leukemia patients with the FLT3-ITD mutationFeifei Tang, Xiaosu Zhao, Guorui Ruan, et al.
Cancers|February 26, 2025
Clinical and Molecular Predictors of Response and Survival Following Venetoclax Plus Hypomethylating Agents in Relapsed/Refractory Acute Myeloid Leukemia: A Single-Center Study in Chinese PatientsLinya Wang, Haitao Gao, Qiang Fu, et al.
Leukemia Research|August 24, 2024
Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3<sup>mut</sup> acute myeloid leukemiaQiang Fu, Yunqi Wang, Hongtao Liu, et al.
Clinical and Experimental Medicine|February 8, 2024
The clinical outcomes of haploidentical stem cell transplantation (haplo-HSCT) for patients with therapy-related myelodysplastic syndrome: comparable to de novo myelodysplastic syndromeFeifei Tang, Yunqi Wang, Yu Wang, et al.
Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan|February 1, 2021
Network pharmacology assessment of Qingkailing injection treatment of cholestatic hepatitisYajun Lian, Qingguo Wang, Jie Mu, et al.
Cancers|July 12, 2025
<i>KDM6A</i> Variants Increased Relapse Risk in Adult Acute Myeloid LeukemiaYijing Zhao, Liting Niu, Sen Yang, et al.
Cancer Medicine|March 12, 2026
Co-Mutation of ASXL1 and KRAS Defines a Novel Ultra-Adverse-Risk Subtype of Acute Myeloid Leukemia in a Large-Scale CohortYijing Zhao, Ting Zhao, Feifei Tang, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Science China. Life Sciences|August 18, 2019
Comparison of the clinical outcomes of hematologic malignancies after myeloablative haploidentical transplantation with G-CSF/ATG and posttransplant cyclophosphamide: results from the Chinese Bone Marrow Transplantation Registry Group (CBMTRG)Feifei Tang, Yajing Xu, Huiren Chen, et al.
Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan|April 7, 2021
Mechanism underlying effect of Chaihu Shugan San on major depressive disorder: a network pharmacology-based studyJie Mu, Shuang Zhang, Feifei Tang, et al.
Leukemia Research|February 13, 2026
Venetoclax and azacitidine versus CAG for unfit patients with newly diagnosed acute myeloid leukemia: A propensity score-matched analysisGuanghui Chang, Haitao Gao, Yan Wei, et al.
Hematological Oncology|June 5, 2023
The effect of haploidentical hematopoietic stem cell transplantation on comutations based on next-generation sequencing in adult acute myeloid leukemia patients with the FLT3-ITD mutationFeifei Tang, Xiaosu Zhao, Guorui Ruan, et al.
Cancers|February 26, 2025
Clinical and Molecular Predictors of Response and Survival Following Venetoclax Plus Hypomethylating Agents in Relapsed/Refractory Acute Myeloid Leukemia: A Single-Center Study in Chinese PatientsLinya Wang, Haitao Gao, Qiang Fu, et al.
Leukemia Research|August 24, 2024
Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3<sup>mut</sup> acute myeloid leukemiaQiang Fu, Yunqi Wang, Hongtao Liu, et al.
Clinical and Experimental Medicine|February 8, 2024
The clinical outcomes of haploidentical stem cell transplantation (haplo-HSCT) for patients with therapy-related myelodysplastic syndrome: comparable to de novo myelodysplastic syndromeFeifei Tang, Yunqi Wang, Yu Wang, et al.
Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan|February 1, 2021
Network pharmacology assessment of Qingkailing injection treatment of cholestatic hepatitisYajun Lian, Qingguo Wang, Jie Mu, et al.
Cancers|July 12, 2025
<i>KDM6A</i> Variants Increased Relapse Risk in Adult Acute Myeloid LeukemiaYijing Zhao, Liting Niu, Sen Yang, et al.
Cancer Medicine|March 12, 2026
Co-Mutation of ASXL1 and KRAS Defines a Novel Ultra-Adverse-Risk Subtype of Acute Myeloid Leukemia in a Large-Scale CohortYijing Zhao, Ting Zhao, Feifei Tang, et al.
Pageof 4